Treating Sudden Deafness with 3 Chinese-western Therapies:Cost-effectiveness Analysis / 中国药房

ABSTRACT

OBJECTIVE:To compare the therapeutic effects and cost-effectiveness among 3 therapeutic regimens. METHODS:85 cases with sudden deafness were divided into 3 groupsGroup A (n=30) were ascribed to receive buflomedil, Group B (n=28) to receive compound Danshen and Group C (n=27) to receive Herba Erigerontis. The curative effects of the 3 were observed and the cost-effectiveness of which were analyzed. RESULTS:The costs of the 3(A, B and C) were 1 908.20yuan, 1 102.68yuan and 1 825.64yuan, respectively. The effective rates of the 3 were 93.33%, 60.71% and 70.37%, respectively. The cost-effectiveness ratios were 20.45yuan, 18.16yuan and 25.94yuan, respectively. As compared with Group B, the incremental costs for Group A and C were 24.73yuan and 74.84yuan, respectively with every one-unit effectiveness increase. CONCLUSION:Group C is the superior one among the 3 therapeutic regimens.